PDF<\/span><\/summary>\n\n![\"\"](\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\")
<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nEditorial Borad<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nArbitrators List<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nContents<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nSupine percutaneous nephrolithotomy in impacted proximal ureteral stones
larger than 15 millimeters; Comparison of flexible ureterorenoscopy and
retroperitoneal laparoscopic ureterolithotomy<\/h3>\n\n\n\n
Taner Karg\u0131, Mithat Ek\u015fi, Ali Ayten, Yunus \u00c7olako\u011flu, Serdar Karada\u011f, \u0130smail Evren, Ahmet Hac\u0131islamo\u011flu, Hakan Polat, Feyzi Arda Atar, Alper Bitkin, Sel\u00e7uk \u015eahin, Ali \u0130hsan Ta\u015f\u00e7\u0131<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective: <\/strong>We aimed to compare the efficacy and safety of supine mini-percutaneous nephrolithotomy
(SMPCNL), retroperitoneal laparoscopic ureterolithotomy (RPUL), and flexible ureterorenoscopy (FURS) in the treatment of impacted proximal ureteral stones larger than 15 mm in diameter.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Data of the patients who underwent SMPCNL, RPUL, and FURS in our institution for proximal ureteral stones between August 2015 and September 2020 were reviewed. Collected data included age, gender, body mass index (BMI) and hydronephrosis grade, stone density, duration of surgery, hospital stay and recovery period, stone-free and demographic data such as complication rates and duration of surgery.<\/p>\n\n\n\nResults: <\/strong>Overall, 162 patients were included. Of these patients, 52 (32.1%) were in Group 1 (SMPCNL
group), 53 (32.7%) were in Group 2 (RPUL group), and 57 (35.2%) ) were in Group 3 (FURS group). Mean operative times were 53\u00b18.2 minutes in Group 1, 63.2\u00b16.6 minutes in Group 2, and 73.7\u00b17.5 minutes in Group 3 (p=0.000). The mean hospital stay was significantly shorter in Group 3 compared to the other groups (p=0.000). The stone-free rates at the initial evaluation were 100%, 90.3%, and 87.7% in the RPUL, SMPCNL, and FURS groups. This rate was significantly lower in the FURS group compared to the other groups (p=0.02).<\/p>\n\n\n\nConclusion: <\/strong>SMPCNL and RPUL procedures are as safe as FURS in treating patients with proximal ureteral stones larger than 15 mm.<\/p>\n\n\n\nKeywords: <\/strong>supine, percutaneous nephrolithotomy, large impacted proximal ureteral stones<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of retrograde intrarenal surgery and percutaneous nephrolithotomy results for 20-30 mm kidney stones: A matched-pair analysis<\/h3>\n\n\n\n
Samet \u015eenel, Muhammed Emin Polat, Kaz\u0131m Ceviz, Emre Uzun, Yusuf Kasap, C\u00fcneyt \u00d6zden, Antonios Koudonas, H\u00fcseyin Cihan Demirel<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> To compare the results of retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones.<\/p>\n\n\n\nMaterial and Methods: <\/strong>The demographic, radiologic, clinic and surgery related data of 324 patients who underwent retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones between January 2013 and July 2022 were retrospectively analyzed. All patients were divided into two groups as retrograde intrarenal surgery group and percutaneous nephrolithotomy group according to the surgery performed. After matching two groups in terms of age, number of stones, location of stones, stone size and stone density, 122 patients were included in the study (61 patients in retrograde intrarenal group and 61 patients in percutaneous nephrolithotomy group as 1:1).<\/p>\n\n\n\nResults: <\/strong>The success rate of retrograde intrarenal surgery group (78.7%) and percutaneous nephrolithotomy group (80.2%) were similar (p=0.823). There was no difference between two groups in terms of infective and non-infective complications (respectively, p=0.752 and p=0.61). There were statistically significant difference between the two groups in duration of operation and hospitalization. The median operation time was 70 (30-100) minutes and the median hospital stay was 1 (1-28) days in the RIRS group, while the median operation time was 90 (50-160) minutes and the median hospital stay was 4 (2-10) days in the PNL group (p<0.001).<\/p>\n\n\n\nConclusion: <\/strong>Retrograde intrarenal surgery is a good alternative in the surgical treatment of 20-30 mm kidney stones with similar success and complication rates and also shorter operation time and hospitalization time.<\/p>\n\n\n\nKeywords: <\/strong>percutaneous nephrolithotomy, retrograde intrarenal surgery, stone, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of preoperative nomograms predicting lymph node invasion in patients underwent radical prostatectomy<\/h3>\n\n\n\n
Osman Can, Cemal Topal, Eyy\u00fcp Dan\u0131\u015f, Muammer Bozkurt, Emin Taha Keskin, Lutfi Canat, Abdulmuttalip \u015eim\u015fek<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In some cases, pelvic lymph node dissection (PLND) is added to radical prostatectomy in the surgical treatment of prostate cancer. Some nomograms have been developed to predict which patient should undergo PLND. In our study, we aimed to evaluate the effectiveness of MSKCC, Briganti and Partin nomograms.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Retrospectively, prostate cancer patients who underwent radical prostatectomy and PLND between September 2020 and October 2022 were included in the study. A total of 94 patients were included in the study. The rates of lymph node invasion were calculated according to the Briganti, MSKCC, and Partin nomograms using the demographic data of the patients and data such as prostate-specific antigen (PSA), clinical stage, gleason score, and biopsy characteristics.<\/p>\n\n\n\nResults: <\/strong>Ninety four patients who had radical prostatectomy were included in the study. While lymph node invasion was reported in 15 of the patients, it was not detected in 79 patients. The area under the curve (AUC)\u2019s of the patients\u2019 Briganti, Partin, and MSKCC nomograms were 0.922, 0.825, and 0.929, respectively. The accuracy rate of all 3 nomograms was statistically significant.<\/p>\n\n\n\nConclusion: <\/strong>The sensitivity of MSKCC and Briganti nomograms in predicting lymph node invasion was found to be slightly higher than Partin nomogram. However, Briganti, Partin, and MSKCC nomograms can be used safely to predict lymph node invasion in prostate cancer patients.<\/p>\n\n\n\nKeywords: <\/strong>Partin, MSKCC, Briganti, prostate cancer<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nThe Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey<\/h3>\n\n\n\n
Mert K\u0131l\u0131\u00e7, Mevlana Derya Balbay<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes. <\/p>\n\n\n\nMaterial and Methods: <\/strong>A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.<\/p>\n\n\n\nResults: <\/strong>The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL\/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention. <\/p>\n\n\n\nConclusion: <\/strong>The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions. <\/p>\n\n\n\n
<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n\n\n\n\n
Editorial Borad<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nArbitrators List<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nContents<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nSupine percutaneous nephrolithotomy in impacted proximal ureteral stones
larger than 15 millimeters; Comparison of flexible ureterorenoscopy and
retroperitoneal laparoscopic ureterolithotomy<\/h3>\n\n\n\n
Taner Karg\u0131, Mithat Ek\u015fi, Ali Ayten, Yunus \u00c7olako\u011flu, Serdar Karada\u011f, \u0130smail Evren, Ahmet Hac\u0131islamo\u011flu, Hakan Polat, Feyzi Arda Atar, Alper Bitkin, Sel\u00e7uk \u015eahin, Ali \u0130hsan Ta\u015f\u00e7\u0131<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective: <\/strong>We aimed to compare the efficacy and safety of supine mini-percutaneous nephrolithotomy
(SMPCNL), retroperitoneal laparoscopic ureterolithotomy (RPUL), and flexible ureterorenoscopy (FURS) in the treatment of impacted proximal ureteral stones larger than 15 mm in diameter.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Data of the patients who underwent SMPCNL, RPUL, and FURS in our institution for proximal ureteral stones between August 2015 and September 2020 were reviewed. Collected data included age, gender, body mass index (BMI) and hydronephrosis grade, stone density, duration of surgery, hospital stay and recovery period, stone-free and demographic data such as complication rates and duration of surgery.<\/p>\n\n\n\nResults: <\/strong>Overall, 162 patients were included. Of these patients, 52 (32.1%) were in Group 1 (SMPCNL
group), 53 (32.7%) were in Group 2 (RPUL group), and 57 (35.2%) ) were in Group 3 (FURS group). Mean operative times were 53\u00b18.2 minutes in Group 1, 63.2\u00b16.6 minutes in Group 2, and 73.7\u00b17.5 minutes in Group 3 (p=0.000). The mean hospital stay was significantly shorter in Group 3 compared to the other groups (p=0.000). The stone-free rates at the initial evaluation were 100%, 90.3%, and 87.7% in the RPUL, SMPCNL, and FURS groups. This rate was significantly lower in the FURS group compared to the other groups (p=0.02).<\/p>\n\n\n\nConclusion: <\/strong>SMPCNL and RPUL procedures are as safe as FURS in treating patients with proximal ureteral stones larger than 15 mm.<\/p>\n\n\n\nKeywords: <\/strong>supine, percutaneous nephrolithotomy, large impacted proximal ureteral stones<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of retrograde intrarenal surgery and percutaneous nephrolithotomy results for 20-30 mm kidney stones: A matched-pair analysis<\/h3>\n\n\n\n
Samet \u015eenel, Muhammed Emin Polat, Kaz\u0131m Ceviz, Emre Uzun, Yusuf Kasap, C\u00fcneyt \u00d6zden, Antonios Koudonas, H\u00fcseyin Cihan Demirel<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> To compare the results of retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones.<\/p>\n\n\n\nMaterial and Methods: <\/strong>The demographic, radiologic, clinic and surgery related data of 324 patients who underwent retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones between January 2013 and July 2022 were retrospectively analyzed. All patients were divided into two groups as retrograde intrarenal surgery group and percutaneous nephrolithotomy group according to the surgery performed. After matching two groups in terms of age, number of stones, location of stones, stone size and stone density, 122 patients were included in the study (61 patients in retrograde intrarenal group and 61 patients in percutaneous nephrolithotomy group as 1:1).<\/p>\n\n\n\nResults: <\/strong>The success rate of retrograde intrarenal surgery group (78.7%) and percutaneous nephrolithotomy group (80.2%) were similar (p=0.823). There was no difference between two groups in terms of infective and non-infective complications (respectively, p=0.752 and p=0.61). There were statistically significant difference between the two groups in duration of operation and hospitalization. The median operation time was 70 (30-100) minutes and the median hospital stay was 1 (1-28) days in the RIRS group, while the median operation time was 90 (50-160) minutes and the median hospital stay was 4 (2-10) days in the PNL group (p<0.001).<\/p>\n\n\n\nConclusion: <\/strong>Retrograde intrarenal surgery is a good alternative in the surgical treatment of 20-30 mm kidney stones with similar success and complication rates and also shorter operation time and hospitalization time.<\/p>\n\n\n\nKeywords: <\/strong>percutaneous nephrolithotomy, retrograde intrarenal surgery, stone, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of preoperative nomograms predicting lymph node invasion in patients underwent radical prostatectomy<\/h3>\n\n\n\n
Osman Can, Cemal Topal, Eyy\u00fcp Dan\u0131\u015f, Muammer Bozkurt, Emin Taha Keskin, Lutfi Canat, Abdulmuttalip \u015eim\u015fek<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In some cases, pelvic lymph node dissection (PLND) is added to radical prostatectomy in the surgical treatment of prostate cancer. Some nomograms have been developed to predict which patient should undergo PLND. In our study, we aimed to evaluate the effectiveness of MSKCC, Briganti and Partin nomograms.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Retrospectively, prostate cancer patients who underwent radical prostatectomy and PLND between September 2020 and October 2022 were included in the study. A total of 94 patients were included in the study. The rates of lymph node invasion were calculated according to the Briganti, MSKCC, and Partin nomograms using the demographic data of the patients and data such as prostate-specific antigen (PSA), clinical stage, gleason score, and biopsy characteristics.<\/p>\n\n\n\nResults: <\/strong>Ninety four patients who had radical prostatectomy were included in the study. While lymph node invasion was reported in 15 of the patients, it was not detected in 79 patients. The area under the curve (AUC)\u2019s of the patients\u2019 Briganti, Partin, and MSKCC nomograms were 0.922, 0.825, and 0.929, respectively. The accuracy rate of all 3 nomograms was statistically significant.<\/p>\n\n\n\nConclusion: <\/strong>The sensitivity of MSKCC and Briganti nomograms in predicting lymph node invasion was found to be slightly higher than Partin nomogram. However, Briganti, Partin, and MSKCC nomograms can be used safely to predict lymph node invasion in prostate cancer patients.<\/p>\n\n\n\nKeywords: <\/strong>Partin, MSKCC, Briganti, prostate cancer<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nThe Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey<\/h3>\n\n\n\n
Mert K\u0131l\u0131\u00e7, Mevlana Derya Balbay<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes. <\/p>\n\n\n\nMaterial and Methods: <\/strong>A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.<\/p>\n\n\n\nResults: <\/strong>The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL\/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention. <\/p>\n\n\n\nConclusion: <\/strong>The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions. <\/p>\n\n\n\n
PDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nArbitrators List<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nContents<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nSupine percutaneous nephrolithotomy in impacted proximal ureteral stones
larger than 15 millimeters; Comparison of flexible ureterorenoscopy and
retroperitoneal laparoscopic ureterolithotomy<\/h3>\n\n\n\n
Taner Karg\u0131, Mithat Ek\u015fi, Ali Ayten, Yunus \u00c7olako\u011flu, Serdar Karada\u011f, \u0130smail Evren, Ahmet Hac\u0131islamo\u011flu, Hakan Polat, Feyzi Arda Atar, Alper Bitkin, Sel\u00e7uk \u015eahin, Ali \u0130hsan Ta\u015f\u00e7\u0131<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective: <\/strong>We aimed to compare the efficacy and safety of supine mini-percutaneous nephrolithotomy
(SMPCNL), retroperitoneal laparoscopic ureterolithotomy (RPUL), and flexible ureterorenoscopy (FURS) in the treatment of impacted proximal ureteral stones larger than 15 mm in diameter.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Data of the patients who underwent SMPCNL, RPUL, and FURS in our institution for proximal ureteral stones between August 2015 and September 2020 were reviewed. Collected data included age, gender, body mass index (BMI) and hydronephrosis grade, stone density, duration of surgery, hospital stay and recovery period, stone-free and demographic data such as complication rates and duration of surgery.<\/p>\n\n\n\nResults: <\/strong>Overall, 162 patients were included. Of these patients, 52 (32.1%) were in Group 1 (SMPCNL
group), 53 (32.7%) were in Group 2 (RPUL group), and 57 (35.2%) ) were in Group 3 (FURS group). Mean operative times were 53\u00b18.2 minutes in Group 1, 63.2\u00b16.6 minutes in Group 2, and 73.7\u00b17.5 minutes in Group 3 (p=0.000). The mean hospital stay was significantly shorter in Group 3 compared to the other groups (p=0.000). The stone-free rates at the initial evaluation were 100%, 90.3%, and 87.7% in the RPUL, SMPCNL, and FURS groups. This rate was significantly lower in the FURS group compared to the other groups (p=0.02).<\/p>\n\n\n\nConclusion: <\/strong>SMPCNL and RPUL procedures are as safe as FURS in treating patients with proximal ureteral stones larger than 15 mm.<\/p>\n\n\n\nKeywords: <\/strong>supine, percutaneous nephrolithotomy, large impacted proximal ureteral stones<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of retrograde intrarenal surgery and percutaneous nephrolithotomy results for 20-30 mm kidney stones: A matched-pair analysis<\/h3>\n\n\n\n
Samet \u015eenel, Muhammed Emin Polat, Kaz\u0131m Ceviz, Emre Uzun, Yusuf Kasap, C\u00fcneyt \u00d6zden, Antonios Koudonas, H\u00fcseyin Cihan Demirel<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> To compare the results of retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones.<\/p>\n\n\n\nMaterial and Methods: <\/strong>The demographic, radiologic, clinic and surgery related data of 324 patients who underwent retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones between January 2013 and July 2022 were retrospectively analyzed. All patients were divided into two groups as retrograde intrarenal surgery group and percutaneous nephrolithotomy group according to the surgery performed. After matching two groups in terms of age, number of stones, location of stones, stone size and stone density, 122 patients were included in the study (61 patients in retrograde intrarenal group and 61 patients in percutaneous nephrolithotomy group as 1:1).<\/p>\n\n\n\nResults: <\/strong>The success rate of retrograde intrarenal surgery group (78.7%) and percutaneous nephrolithotomy group (80.2%) were similar (p=0.823). There was no difference between two groups in terms of infective and non-infective complications (respectively, p=0.752 and p=0.61). There were statistically significant difference between the two groups in duration of operation and hospitalization. The median operation time was 70 (30-100) minutes and the median hospital stay was 1 (1-28) days in the RIRS group, while the median operation time was 90 (50-160) minutes and the median hospital stay was 4 (2-10) days in the PNL group (p<0.001).<\/p>\n\n\n\nConclusion: <\/strong>Retrograde intrarenal surgery is a good alternative in the surgical treatment of 20-30 mm kidney stones with similar success and complication rates and also shorter operation time and hospitalization time.<\/p>\n\n\n\nKeywords: <\/strong>percutaneous nephrolithotomy, retrograde intrarenal surgery, stone, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of preoperative nomograms predicting lymph node invasion in patients underwent radical prostatectomy<\/h3>\n\n\n\n
Osman Can, Cemal Topal, Eyy\u00fcp Dan\u0131\u015f, Muammer Bozkurt, Emin Taha Keskin, Lutfi Canat, Abdulmuttalip \u015eim\u015fek<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In some cases, pelvic lymph node dissection (PLND) is added to radical prostatectomy in the surgical treatment of prostate cancer. Some nomograms have been developed to predict which patient should undergo PLND. In our study, we aimed to evaluate the effectiveness of MSKCC, Briganti and Partin nomograms.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Retrospectively, prostate cancer patients who underwent radical prostatectomy and PLND between September 2020 and October 2022 were included in the study. A total of 94 patients were included in the study. The rates of lymph node invasion were calculated according to the Briganti, MSKCC, and Partin nomograms using the demographic data of the patients and data such as prostate-specific antigen (PSA), clinical stage, gleason score, and biopsy characteristics.<\/p>\n\n\n\nResults: <\/strong>Ninety four patients who had radical prostatectomy were included in the study. While lymph node invasion was reported in 15 of the patients, it was not detected in 79 patients. The area under the curve (AUC)\u2019s of the patients\u2019 Briganti, Partin, and MSKCC nomograms were 0.922, 0.825, and 0.929, respectively. The accuracy rate of all 3 nomograms was statistically significant.<\/p>\n\n\n\nConclusion: <\/strong>The sensitivity of MSKCC and Briganti nomograms in predicting lymph node invasion was found to be slightly higher than Partin nomogram. However, Briganti, Partin, and MSKCC nomograms can be used safely to predict lymph node invasion in prostate cancer patients.<\/p>\n\n\n\nKeywords: <\/strong>Partin, MSKCC, Briganti, prostate cancer<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nThe Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey<\/h3>\n\n\n\n
Mert K\u0131l\u0131\u00e7, Mevlana Derya Balbay<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes. <\/p>\n\n\n\nMaterial and Methods: <\/strong>A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.<\/p>\n\n\n\nResults: <\/strong>The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL\/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention. <\/p>\n\n\n\nConclusion: <\/strong>The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions. <\/p>\n\n\n\n
<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n\n\n\n\n
Arbitrators List<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nContents<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nSupine percutaneous nephrolithotomy in impacted proximal ureteral stones
larger than 15 millimeters; Comparison of flexible ureterorenoscopy and
retroperitoneal laparoscopic ureterolithotomy<\/h3>\n\n\n\n
Taner Karg\u0131, Mithat Ek\u015fi, Ali Ayten, Yunus \u00c7olako\u011flu, Serdar Karada\u011f, \u0130smail Evren, Ahmet Hac\u0131islamo\u011flu, Hakan Polat, Feyzi Arda Atar, Alper Bitkin, Sel\u00e7uk \u015eahin, Ali \u0130hsan Ta\u015f\u00e7\u0131<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective: <\/strong>We aimed to compare the efficacy and safety of supine mini-percutaneous nephrolithotomy
(SMPCNL), retroperitoneal laparoscopic ureterolithotomy (RPUL), and flexible ureterorenoscopy (FURS) in the treatment of impacted proximal ureteral stones larger than 15 mm in diameter.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Data of the patients who underwent SMPCNL, RPUL, and FURS in our institution for proximal ureteral stones between August 2015 and September 2020 were reviewed. Collected data included age, gender, body mass index (BMI) and hydronephrosis grade, stone density, duration of surgery, hospital stay and recovery period, stone-free and demographic data such as complication rates and duration of surgery.<\/p>\n\n\n\nResults: <\/strong>Overall, 162 patients were included. Of these patients, 52 (32.1%) were in Group 1 (SMPCNL
group), 53 (32.7%) were in Group 2 (RPUL group), and 57 (35.2%) ) were in Group 3 (FURS group). Mean operative times were 53\u00b18.2 minutes in Group 1, 63.2\u00b16.6 minutes in Group 2, and 73.7\u00b17.5 minutes in Group 3 (p=0.000). The mean hospital stay was significantly shorter in Group 3 compared to the other groups (p=0.000). The stone-free rates at the initial evaluation were 100%, 90.3%, and 87.7% in the RPUL, SMPCNL, and FURS groups. This rate was significantly lower in the FURS group compared to the other groups (p=0.02).<\/p>\n\n\n\nConclusion: <\/strong>SMPCNL and RPUL procedures are as safe as FURS in treating patients with proximal ureteral stones larger than 15 mm.<\/p>\n\n\n\nKeywords: <\/strong>supine, percutaneous nephrolithotomy, large impacted proximal ureteral stones<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of retrograde intrarenal surgery and percutaneous nephrolithotomy results for 20-30 mm kidney stones: A matched-pair analysis<\/h3>\n\n\n\n
Samet \u015eenel, Muhammed Emin Polat, Kaz\u0131m Ceviz, Emre Uzun, Yusuf Kasap, C\u00fcneyt \u00d6zden, Antonios Koudonas, H\u00fcseyin Cihan Demirel<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> To compare the results of retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones.<\/p>\n\n\n\nMaterial and Methods: <\/strong>The demographic, radiologic, clinic and surgery related data of 324 patients who underwent retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones between January 2013 and July 2022 were retrospectively analyzed. All patients were divided into two groups as retrograde intrarenal surgery group and percutaneous nephrolithotomy group according to the surgery performed. After matching two groups in terms of age, number of stones, location of stones, stone size and stone density, 122 patients were included in the study (61 patients in retrograde intrarenal group and 61 patients in percutaneous nephrolithotomy group as 1:1).<\/p>\n\n\n\nResults: <\/strong>The success rate of retrograde intrarenal surgery group (78.7%) and percutaneous nephrolithotomy group (80.2%) were similar (p=0.823). There was no difference between two groups in terms of infective and non-infective complications (respectively, p=0.752 and p=0.61). There were statistically significant difference between the two groups in duration of operation and hospitalization. The median operation time was 70 (30-100) minutes and the median hospital stay was 1 (1-28) days in the RIRS group, while the median operation time was 90 (50-160) minutes and the median hospital stay was 4 (2-10) days in the PNL group (p<0.001).<\/p>\n\n\n\nConclusion: <\/strong>Retrograde intrarenal surgery is a good alternative in the surgical treatment of 20-30 mm kidney stones with similar success and complication rates and also shorter operation time and hospitalization time.<\/p>\n\n\n\nKeywords: <\/strong>percutaneous nephrolithotomy, retrograde intrarenal surgery, stone, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of preoperative nomograms predicting lymph node invasion in patients underwent radical prostatectomy<\/h3>\n\n\n\n
Osman Can, Cemal Topal, Eyy\u00fcp Dan\u0131\u015f, Muammer Bozkurt, Emin Taha Keskin, Lutfi Canat, Abdulmuttalip \u015eim\u015fek<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In some cases, pelvic lymph node dissection (PLND) is added to radical prostatectomy in the surgical treatment of prostate cancer. Some nomograms have been developed to predict which patient should undergo PLND. In our study, we aimed to evaluate the effectiveness of MSKCC, Briganti and Partin nomograms.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Retrospectively, prostate cancer patients who underwent radical prostatectomy and PLND between September 2020 and October 2022 were included in the study. A total of 94 patients were included in the study. The rates of lymph node invasion were calculated according to the Briganti, MSKCC, and Partin nomograms using the demographic data of the patients and data such as prostate-specific antigen (PSA), clinical stage, gleason score, and biopsy characteristics.<\/p>\n\n\n\nResults: <\/strong>Ninety four patients who had radical prostatectomy were included in the study. While lymph node invasion was reported in 15 of the patients, it was not detected in 79 patients. The area under the curve (AUC)\u2019s of the patients\u2019 Briganti, Partin, and MSKCC nomograms were 0.922, 0.825, and 0.929, respectively. The accuracy rate of all 3 nomograms was statistically significant.<\/p>\n\n\n\nConclusion: <\/strong>The sensitivity of MSKCC and Briganti nomograms in predicting lymph node invasion was found to be slightly higher than Partin nomogram. However, Briganti, Partin, and MSKCC nomograms can be used safely to predict lymph node invasion in prostate cancer patients.<\/p>\n\n\n\nKeywords: <\/strong>Partin, MSKCC, Briganti, prostate cancer<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nThe Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey<\/h3>\n\n\n\n
Mert K\u0131l\u0131\u00e7, Mevlana Derya Balbay<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes. <\/p>\n\n\n\nMaterial and Methods: <\/strong>A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.<\/p>\n\n\n\nResults: <\/strong>The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL\/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention. <\/p>\n\n\n\nConclusion: <\/strong>The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions. <\/p>\n\n\n\n
PDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nContents<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nSupine percutaneous nephrolithotomy in impacted proximal ureteral stones
larger than 15 millimeters; Comparison of flexible ureterorenoscopy and
retroperitoneal laparoscopic ureterolithotomy<\/h3>\n\n\n\n
Taner Karg\u0131, Mithat Ek\u015fi, Ali Ayten, Yunus \u00c7olako\u011flu, Serdar Karada\u011f, \u0130smail Evren, Ahmet Hac\u0131islamo\u011flu, Hakan Polat, Feyzi Arda Atar, Alper Bitkin, Sel\u00e7uk \u015eahin, Ali \u0130hsan Ta\u015f\u00e7\u0131<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective: <\/strong>We aimed to compare the efficacy and safety of supine mini-percutaneous nephrolithotomy
(SMPCNL), retroperitoneal laparoscopic ureterolithotomy (RPUL), and flexible ureterorenoscopy (FURS) in the treatment of impacted proximal ureteral stones larger than 15 mm in diameter.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Data of the patients who underwent SMPCNL, RPUL, and FURS in our institution for proximal ureteral stones between August 2015 and September 2020 were reviewed. Collected data included age, gender, body mass index (BMI) and hydronephrosis grade, stone density, duration of surgery, hospital stay and recovery period, stone-free and demographic data such as complication rates and duration of surgery.<\/p>\n\n\n\nResults: <\/strong>Overall, 162 patients were included. Of these patients, 52 (32.1%) were in Group 1 (SMPCNL
group), 53 (32.7%) were in Group 2 (RPUL group), and 57 (35.2%) ) were in Group 3 (FURS group). Mean operative times were 53\u00b18.2 minutes in Group 1, 63.2\u00b16.6 minutes in Group 2, and 73.7\u00b17.5 minutes in Group 3 (p=0.000). The mean hospital stay was significantly shorter in Group 3 compared to the other groups (p=0.000). The stone-free rates at the initial evaluation were 100%, 90.3%, and 87.7% in the RPUL, SMPCNL, and FURS groups. This rate was significantly lower in the FURS group compared to the other groups (p=0.02).<\/p>\n\n\n\nConclusion: <\/strong>SMPCNL and RPUL procedures are as safe as FURS in treating patients with proximal ureteral stones larger than 15 mm.<\/p>\n\n\n\nKeywords: <\/strong>supine, percutaneous nephrolithotomy, large impacted proximal ureteral stones<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of retrograde intrarenal surgery and percutaneous nephrolithotomy results for 20-30 mm kidney stones: A matched-pair analysis<\/h3>\n\n\n\n
Samet \u015eenel, Muhammed Emin Polat, Kaz\u0131m Ceviz, Emre Uzun, Yusuf Kasap, C\u00fcneyt \u00d6zden, Antonios Koudonas, H\u00fcseyin Cihan Demirel<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> To compare the results of retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones.<\/p>\n\n\n\nMaterial and Methods: <\/strong>The demographic, radiologic, clinic and surgery related data of 324 patients who underwent retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones between January 2013 and July 2022 were retrospectively analyzed. All patients were divided into two groups as retrograde intrarenal surgery group and percutaneous nephrolithotomy group according to the surgery performed. After matching two groups in terms of age, number of stones, location of stones, stone size and stone density, 122 patients were included in the study (61 patients in retrograde intrarenal group and 61 patients in percutaneous nephrolithotomy group as 1:1).<\/p>\n\n\n\nResults: <\/strong>The success rate of retrograde intrarenal surgery group (78.7%) and percutaneous nephrolithotomy group (80.2%) were similar (p=0.823). There was no difference between two groups in terms of infective and non-infective complications (respectively, p=0.752 and p=0.61). There were statistically significant difference between the two groups in duration of operation and hospitalization. The median operation time was 70 (30-100) minutes and the median hospital stay was 1 (1-28) days in the RIRS group, while the median operation time was 90 (50-160) minutes and the median hospital stay was 4 (2-10) days in the PNL group (p<0.001).<\/p>\n\n\n\nConclusion: <\/strong>Retrograde intrarenal surgery is a good alternative in the surgical treatment of 20-30 mm kidney stones with similar success and complication rates and also shorter operation time and hospitalization time.<\/p>\n\n\n\nKeywords: <\/strong>percutaneous nephrolithotomy, retrograde intrarenal surgery, stone, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of preoperative nomograms predicting lymph node invasion in patients underwent radical prostatectomy<\/h3>\n\n\n\n
Osman Can, Cemal Topal, Eyy\u00fcp Dan\u0131\u015f, Muammer Bozkurt, Emin Taha Keskin, Lutfi Canat, Abdulmuttalip \u015eim\u015fek<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In some cases, pelvic lymph node dissection (PLND) is added to radical prostatectomy in the surgical treatment of prostate cancer. Some nomograms have been developed to predict which patient should undergo PLND. In our study, we aimed to evaluate the effectiveness of MSKCC, Briganti and Partin nomograms.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Retrospectively, prostate cancer patients who underwent radical prostatectomy and PLND between September 2020 and October 2022 were included in the study. A total of 94 patients were included in the study. The rates of lymph node invasion were calculated according to the Briganti, MSKCC, and Partin nomograms using the demographic data of the patients and data such as prostate-specific antigen (PSA), clinical stage, gleason score, and biopsy characteristics.<\/p>\n\n\n\nResults: <\/strong>Ninety four patients who had radical prostatectomy were included in the study. While lymph node invasion was reported in 15 of the patients, it was not detected in 79 patients. The area under the curve (AUC)\u2019s of the patients\u2019 Briganti, Partin, and MSKCC nomograms were 0.922, 0.825, and 0.929, respectively. The accuracy rate of all 3 nomograms was statistically significant.<\/p>\n\n\n\nConclusion: <\/strong>The sensitivity of MSKCC and Briganti nomograms in predicting lymph node invasion was found to be slightly higher than Partin nomogram. However, Briganti, Partin, and MSKCC nomograms can be used safely to predict lymph node invasion in prostate cancer patients.<\/p>\n\n\n\nKeywords: <\/strong>Partin, MSKCC, Briganti, prostate cancer<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nThe Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey<\/h3>\n\n\n\n
Mert K\u0131l\u0131\u00e7, Mevlana Derya Balbay<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes. <\/p>\n\n\n\nMaterial and Methods: <\/strong>A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.<\/p>\n\n\n\nResults: <\/strong>The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL\/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention. <\/p>\n\n\n\nConclusion: <\/strong>The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions. <\/p>\n\n\n\n
<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n\n\n\n\n
Contents<\/h3>\n\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nSupine percutaneous nephrolithotomy in impacted proximal ureteral stones
larger than 15 millimeters; Comparison of flexible ureterorenoscopy and
retroperitoneal laparoscopic ureterolithotomy<\/h3>\n\n\n\n
Taner Karg\u0131, Mithat Ek\u015fi, Ali Ayten, Yunus \u00c7olako\u011flu, Serdar Karada\u011f, \u0130smail Evren, Ahmet Hac\u0131islamo\u011flu, Hakan Polat, Feyzi Arda Atar, Alper Bitkin, Sel\u00e7uk \u015eahin, Ali \u0130hsan Ta\u015f\u00e7\u0131<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective: <\/strong>We aimed to compare the efficacy and safety of supine mini-percutaneous nephrolithotomy
(SMPCNL), retroperitoneal laparoscopic ureterolithotomy (RPUL), and flexible ureterorenoscopy (FURS) in the treatment of impacted proximal ureteral stones larger than 15 mm in diameter.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Data of the patients who underwent SMPCNL, RPUL, and FURS in our institution for proximal ureteral stones between August 2015 and September 2020 were reviewed. Collected data included age, gender, body mass index (BMI) and hydronephrosis grade, stone density, duration of surgery, hospital stay and recovery period, stone-free and demographic data such as complication rates and duration of surgery.<\/p>\n\n\n\nResults: <\/strong>Overall, 162 patients were included. Of these patients, 52 (32.1%) were in Group 1 (SMPCNL
group), 53 (32.7%) were in Group 2 (RPUL group), and 57 (35.2%) ) were in Group 3 (FURS group). Mean operative times were 53\u00b18.2 minutes in Group 1, 63.2\u00b16.6 minutes in Group 2, and 73.7\u00b17.5 minutes in Group 3 (p=0.000). The mean hospital stay was significantly shorter in Group 3 compared to the other groups (p=0.000). The stone-free rates at the initial evaluation were 100%, 90.3%, and 87.7% in the RPUL, SMPCNL, and FURS groups. This rate was significantly lower in the FURS group compared to the other groups (p=0.02).<\/p>\n\n\n\nConclusion: <\/strong>SMPCNL and RPUL procedures are as safe as FURS in treating patients with proximal ureteral stones larger than 15 mm.<\/p>\n\n\n\nKeywords: <\/strong>supine, percutaneous nephrolithotomy, large impacted proximal ureteral stones<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of retrograde intrarenal surgery and percutaneous nephrolithotomy results for 20-30 mm kidney stones: A matched-pair analysis<\/h3>\n\n\n\n
Samet \u015eenel, Muhammed Emin Polat, Kaz\u0131m Ceviz, Emre Uzun, Yusuf Kasap, C\u00fcneyt \u00d6zden, Antonios Koudonas, H\u00fcseyin Cihan Demirel<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> To compare the results of retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones.<\/p>\n\n\n\nMaterial and Methods: <\/strong>The demographic, radiologic, clinic and surgery related data of 324 patients who underwent retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones between January 2013 and July 2022 were retrospectively analyzed. All patients were divided into two groups as retrograde intrarenal surgery group and percutaneous nephrolithotomy group according to the surgery performed. After matching two groups in terms of age, number of stones, location of stones, stone size and stone density, 122 patients were included in the study (61 patients in retrograde intrarenal group and 61 patients in percutaneous nephrolithotomy group as 1:1).<\/p>\n\n\n\nResults: <\/strong>The success rate of retrograde intrarenal surgery group (78.7%) and percutaneous nephrolithotomy group (80.2%) were similar (p=0.823). There was no difference between two groups in terms of infective and non-infective complications (respectively, p=0.752 and p=0.61). There were statistically significant difference between the two groups in duration of operation and hospitalization. The median operation time was 70 (30-100) minutes and the median hospital stay was 1 (1-28) days in the RIRS group, while the median operation time was 90 (50-160) minutes and the median hospital stay was 4 (2-10) days in the PNL group (p<0.001).<\/p>\n\n\n\nConclusion: <\/strong>Retrograde intrarenal surgery is a good alternative in the surgical treatment of 20-30 mm kidney stones with similar success and complication rates and also shorter operation time and hospitalization time.<\/p>\n\n\n\nKeywords: <\/strong>percutaneous nephrolithotomy, retrograde intrarenal surgery, stone, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of preoperative nomograms predicting lymph node invasion in patients underwent radical prostatectomy<\/h3>\n\n\n\n
Osman Can, Cemal Topal, Eyy\u00fcp Dan\u0131\u015f, Muammer Bozkurt, Emin Taha Keskin, Lutfi Canat, Abdulmuttalip \u015eim\u015fek<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In some cases, pelvic lymph node dissection (PLND) is added to radical prostatectomy in the surgical treatment of prostate cancer. Some nomograms have been developed to predict which patient should undergo PLND. In our study, we aimed to evaluate the effectiveness of MSKCC, Briganti and Partin nomograms.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Retrospectively, prostate cancer patients who underwent radical prostatectomy and PLND between September 2020 and October 2022 were included in the study. A total of 94 patients were included in the study. The rates of lymph node invasion were calculated according to the Briganti, MSKCC, and Partin nomograms using the demographic data of the patients and data such as prostate-specific antigen (PSA), clinical stage, gleason score, and biopsy characteristics.<\/p>\n\n\n\nResults: <\/strong>Ninety four patients who had radical prostatectomy were included in the study. While lymph node invasion was reported in 15 of the patients, it was not detected in 79 patients. The area under the curve (AUC)\u2019s of the patients\u2019 Briganti, Partin, and MSKCC nomograms were 0.922, 0.825, and 0.929, respectively. The accuracy rate of all 3 nomograms was statistically significant.<\/p>\n\n\n\nConclusion: <\/strong>The sensitivity of MSKCC and Briganti nomograms in predicting lymph node invasion was found to be slightly higher than Partin nomogram. However, Briganti, Partin, and MSKCC nomograms can be used safely to predict lymph node invasion in prostate cancer patients.<\/p>\n\n\n\nKeywords: <\/strong>Partin, MSKCC, Briganti, prostate cancer<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nThe Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey<\/h3>\n\n\n\n
Mert K\u0131l\u0131\u00e7, Mevlana Derya Balbay<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes. <\/p>\n\n\n\nMaterial and Methods: <\/strong>A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.<\/p>\n\n\n\nResults: <\/strong>The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL\/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention. <\/p>\n\n\n\nConclusion: <\/strong>The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions. <\/p>\n\n\n\n
PDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nSupine percutaneous nephrolithotomy in impacted proximal ureteral stones
larger than 15 millimeters; Comparison of flexible ureterorenoscopy and
retroperitoneal laparoscopic ureterolithotomy<\/h3>\n\n\n\n
Taner Karg\u0131, Mithat Ek\u015fi, Ali Ayten, Yunus \u00c7olako\u011flu, Serdar Karada\u011f, \u0130smail Evren, Ahmet Hac\u0131islamo\u011flu, Hakan Polat, Feyzi Arda Atar, Alper Bitkin, Sel\u00e7uk \u015eahin, Ali \u0130hsan Ta\u015f\u00e7\u0131<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective: <\/strong>We aimed to compare the efficacy and safety of supine mini-percutaneous nephrolithotomy
(SMPCNL), retroperitoneal laparoscopic ureterolithotomy (RPUL), and flexible ureterorenoscopy (FURS) in the treatment of impacted proximal ureteral stones larger than 15 mm in diameter.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Data of the patients who underwent SMPCNL, RPUL, and FURS in our institution for proximal ureteral stones between August 2015 and September 2020 were reviewed. Collected data included age, gender, body mass index (BMI) and hydronephrosis grade, stone density, duration of surgery, hospital stay and recovery period, stone-free and demographic data such as complication rates and duration of surgery.<\/p>\n\n\n\nResults: <\/strong>Overall, 162 patients were included. Of these patients, 52 (32.1%) were in Group 1 (SMPCNL
group), 53 (32.7%) were in Group 2 (RPUL group), and 57 (35.2%) ) were in Group 3 (FURS group). Mean operative times were 53\u00b18.2 minutes in Group 1, 63.2\u00b16.6 minutes in Group 2, and 73.7\u00b17.5 minutes in Group 3 (p=0.000). The mean hospital stay was significantly shorter in Group 3 compared to the other groups (p=0.000). The stone-free rates at the initial evaluation were 100%, 90.3%, and 87.7% in the RPUL, SMPCNL, and FURS groups. This rate was significantly lower in the FURS group compared to the other groups (p=0.02).<\/p>\n\n\n\nConclusion: <\/strong>SMPCNL and RPUL procedures are as safe as FURS in treating patients with proximal ureteral stones larger than 15 mm.<\/p>\n\n\n\nKeywords: <\/strong>supine, percutaneous nephrolithotomy, large impacted proximal ureteral stones<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of retrograde intrarenal surgery and percutaneous nephrolithotomy results for 20-30 mm kidney stones: A matched-pair analysis<\/h3>\n\n\n\n
Samet \u015eenel, Muhammed Emin Polat, Kaz\u0131m Ceviz, Emre Uzun, Yusuf Kasap, C\u00fcneyt \u00d6zden, Antonios Koudonas, H\u00fcseyin Cihan Demirel<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> To compare the results of retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones.<\/p>\n\n\n\nMaterial and Methods: <\/strong>The demographic, radiologic, clinic and surgery related data of 324 patients who underwent retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones between January 2013 and July 2022 were retrospectively analyzed. All patients were divided into two groups as retrograde intrarenal surgery group and percutaneous nephrolithotomy group according to the surgery performed. After matching two groups in terms of age, number of stones, location of stones, stone size and stone density, 122 patients were included in the study (61 patients in retrograde intrarenal group and 61 patients in percutaneous nephrolithotomy group as 1:1).<\/p>\n\n\n\nResults: <\/strong>The success rate of retrograde intrarenal surgery group (78.7%) and percutaneous nephrolithotomy group (80.2%) were similar (p=0.823). There was no difference between two groups in terms of infective and non-infective complications (respectively, p=0.752 and p=0.61). There were statistically significant difference between the two groups in duration of operation and hospitalization. The median operation time was 70 (30-100) minutes and the median hospital stay was 1 (1-28) days in the RIRS group, while the median operation time was 90 (50-160) minutes and the median hospital stay was 4 (2-10) days in the PNL group (p<0.001).<\/p>\n\n\n\nConclusion: <\/strong>Retrograde intrarenal surgery is a good alternative in the surgical treatment of 20-30 mm kidney stones with similar success and complication rates and also shorter operation time and hospitalization time.<\/p>\n\n\n\nKeywords: <\/strong>percutaneous nephrolithotomy, retrograde intrarenal surgery, stone, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nComparison of preoperative nomograms predicting lymph node invasion in patients underwent radical prostatectomy<\/h3>\n\n\n\n
Osman Can, Cemal Topal, Eyy\u00fcp Dan\u0131\u015f, Muammer Bozkurt, Emin Taha Keskin, Lutfi Canat, Abdulmuttalip \u015eim\u015fek<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In some cases, pelvic lymph node dissection (PLND) is added to radical prostatectomy in the surgical treatment of prostate cancer. Some nomograms have been developed to predict which patient should undergo PLND. In our study, we aimed to evaluate the effectiveness of MSKCC, Briganti and Partin nomograms.<\/p>\n\n\n\nMaterial and Methods: <\/strong>Retrospectively, prostate cancer patients who underwent radical prostatectomy and PLND between September 2020 and October 2022 were included in the study. A total of 94 patients were included in the study. The rates of lymph node invasion were calculated according to the Briganti, MSKCC, and Partin nomograms using the demographic data of the patients and data such as prostate-specific antigen (PSA), clinical stage, gleason score, and biopsy characteristics.<\/p>\n\n\n\nResults: <\/strong>Ninety four patients who had radical prostatectomy were included in the study. While lymph node invasion was reported in 15 of the patients, it was not detected in 79 patients. The area under the curve (AUC)\u2019s of the patients\u2019 Briganti, Partin, and MSKCC nomograms were 0.922, 0.825, and 0.929, respectively. The accuracy rate of all 3 nomograms was statistically significant.<\/p>\n\n\n\nConclusion: <\/strong>The sensitivity of MSKCC and Briganti nomograms in predicting lymph node invasion was found to be slightly higher than Partin nomogram. However, Briganti, Partin, and MSKCC nomograms can be used safely to predict lymph node invasion in prostate cancer patients.<\/p>\n\n\n\nKeywords: <\/strong>Partin, MSKCC, Briganti, prostate cancer<\/p>\n\n<\/div><\/details><\/div>\n\nPDF<\/span><\/summary>\n\n<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nOriginal Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\nThe Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey<\/h3>\n\n\n\n
Mert K\u0131l\u0131\u00e7, Mevlana Derya Balbay<\/p>\n\n\n
Abstract<\/span><\/summary>\n\nObjective:<\/strong> In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes. <\/p>\n\n\n\nMaterial and Methods: <\/strong>A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.<\/p>\n\n\n\nResults: <\/strong>The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL\/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention. <\/p>\n\n\n\nConclusion: <\/strong>The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions. <\/p>\n\n\n\n
<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n\n\n\n\n
Original Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\n Taner Karg\u0131, Mithat Ek\u015fi, Ali Ayten, Yunus \u00c7olako\u011flu, Serdar Karada\u011f, \u0130smail Evren, Ahmet Hac\u0131islamo\u011flu, Hakan Polat, Feyzi Arda Atar, Alper Bitkin, Sel\u00e7uk \u015eahin, Ali \u0130hsan Ta\u015f\u00e7\u0131<\/p>\n\n\n Objective: <\/strong>We aimed to compare the efficacy and safety of supine mini-percutaneous nephrolithotomy Material and Methods: <\/strong>Data of the patients who underwent SMPCNL, RPUL, and FURS in our institution for proximal ureteral stones between August 2015 and September 2020 were reviewed. Collected data included age, gender, body mass index (BMI) and hydronephrosis grade, stone density, duration of surgery, hospital stay and recovery period, stone-free and demographic data such as complication rates and duration of surgery.<\/p>\n\n\n\n Results: <\/strong>Overall, 162 patients were included. Of these patients, 52 (32.1%) were in Group 1 (SMPCNL Conclusion: <\/strong>SMPCNL and RPUL procedures are as safe as FURS in treating patients with proximal ureteral stones larger than 15 mm.<\/p>\n\n\n\n Keywords: <\/strong>supine, percutaneous nephrolithotomy, large impacted proximal ureteral stones<\/p>\n\n<\/div><\/details><\/div>\n\n Original Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\n Samet \u015eenel, Muhammed Emin Polat, Kaz\u0131m Ceviz, Emre Uzun, Yusuf Kasap, C\u00fcneyt \u00d6zden, Antonios Koudonas, H\u00fcseyin Cihan Demirel<\/p>\n\n\n Objective:<\/strong> To compare the results of retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones.<\/p>\n\n\n\n Material and Methods: <\/strong>The demographic, radiologic, clinic and surgery related data of 324 patients who underwent retrograde intrarenal surgery and percutaneous nephrolithotomy for 20-30 mm kidney stones between January 2013 and July 2022 were retrospectively analyzed. All patients were divided into two groups as retrograde intrarenal surgery group and percutaneous nephrolithotomy group according to the surgery performed. After matching two groups in terms of age, number of stones, location of stones, stone size and stone density, 122 patients were included in the study (61 patients in retrograde intrarenal group and 61 patients in percutaneous nephrolithotomy group as 1:1).<\/p>\n\n\n\n Results: <\/strong>The success rate of retrograde intrarenal surgery group (78.7%) and percutaneous nephrolithotomy group (80.2%) were similar (p=0.823). There was no difference between two groups in terms of infective and non-infective complications (respectively, p=0.752 and p=0.61). There were statistically significant difference between the two groups in duration of operation and hospitalization. The median operation time was 70 (30-100) minutes and the median hospital stay was 1 (1-28) days in the RIRS group, while the median operation time was 90 (50-160) minutes and the median hospital stay was 4 (2-10) days in the PNL group (p<0.001).<\/p>\n\n\n\n Conclusion: <\/strong>Retrograde intrarenal surgery is a good alternative in the surgical treatment of 20-30 mm kidney stones with similar success and complication rates and also shorter operation time and hospitalization time.<\/p>\n\n\n\n Keywords: <\/strong>percutaneous nephrolithotomy, retrograde intrarenal surgery, stone, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\n Original Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\n Osman Can, Cemal Topal, Eyy\u00fcp Dan\u0131\u015f, Muammer Bozkurt, Emin Taha Keskin, Lutfi Canat, Abdulmuttalip \u015eim\u015fek<\/p>\n\n\n Objective:<\/strong> In some cases, pelvic lymph node dissection (PLND) is added to radical prostatectomy in the surgical treatment of prostate cancer. Some nomograms have been developed to predict which patient should undergo PLND. In our study, we aimed to evaluate the effectiveness of MSKCC, Briganti and Partin nomograms.<\/p>\n\n\n\n Material and Methods: <\/strong>Retrospectively, prostate cancer patients who underwent radical prostatectomy and PLND between September 2020 and October 2022 were included in the study. A total of 94 patients were included in the study. The rates of lymph node invasion were calculated according to the Briganti, MSKCC, and Partin nomograms using the demographic data of the patients and data such as prostate-specific antigen (PSA), clinical stage, gleason score, and biopsy characteristics.<\/p>\n\n\n\n Results: <\/strong>Ninety four patients who had radical prostatectomy were included in the study. While lymph node invasion was reported in 15 of the patients, it was not detected in 79 patients. The area under the curve (AUC)\u2019s of the patients\u2019 Briganti, Partin, and MSKCC nomograms were 0.922, 0.825, and 0.929, respectively. The accuracy rate of all 3 nomograms was statistically significant.<\/p>\n\n\n\n Conclusion: <\/strong>The sensitivity of MSKCC and Briganti nomograms in predicting lymph node invasion was found to be slightly higher than Partin nomogram. However, Briganti, Partin, and MSKCC nomograms can be used safely to predict lymph node invasion in prostate cancer patients.<\/p>\n\n\n\n Keywords: <\/strong>Partin, MSKCC, Briganti, prostate cancer<\/p>\n\n<\/div><\/details><\/div>\n\n Original Article<\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/strong><\/p>\n\n\n\n Mert K\u0131l\u0131\u00e7, Mevlana Derya Balbay<\/p>\n\n\n Objective:<\/strong> In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes. <\/p>\n\n\n\n Material and Methods: <\/strong>A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.<\/p>\n\n\n\n Results: <\/strong>The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL\/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention. <\/p>\n\n\n\n Conclusion: <\/strong>The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions. <\/p>\n\n\n\nSupine percutaneous nephrolithotomy in impacted proximal ureteral stones
larger than 15 millimeters; Comparison of flexible ureterorenoscopy and
retroperitoneal laparoscopic ureterolithotomy<\/h3>\n\n\n\nAbstract<\/span><\/summary>
(SMPCNL), retroperitoneal laparoscopic ureterolithotomy (RPUL), and flexible ureterorenoscopy (FURS) in the treatment of impacted proximal ureteral stones larger than 15 mm in diameter.<\/p>\n\n\n\n
group), 53 (32.7%) were in Group 2 (RPUL group), and 57 (35.2%) ) were in Group 3 (FURS group). Mean operative times were 53\u00b18.2 minutes in Group 1, 63.2\u00b16.6 minutes in Group 2, and 73.7\u00b17.5 minutes in Group 3 (p=0.000). The mean hospital stay was significantly shorter in Group 3 compared to the other groups (p=0.000). The stone-free rates at the initial evaluation were 100%, 90.3%, and 87.7% in the RPUL, SMPCNL, and FURS groups. This rate was significantly lower in the FURS group compared to the other groups (p=0.02).<\/p>\n\n\n\nPDF<\/span><\/summary>
<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nComparison of retrograde intrarenal surgery and percutaneous nephrolithotomy results for 20-30 mm kidney stones: A matched-pair analysis<\/h3>\n\n\n\n
Abstract<\/span><\/summary>
PDF<\/span><\/summary>
<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nComparison of preoperative nomograms predicting lymph node invasion in patients underwent radical prostatectomy<\/h3>\n\n\n\n
Abstract<\/span><\/summary>
PDF<\/span><\/summary>
<\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n
\n\n\n\nThe Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey<\/h3>\n\n\n\n
Abstract<\/span><\/summary>